Invex Therapeutics Ltd (ASX:IXC) Share Price and News - StockTrack

Market Cap (1-Jul) $6,688,688 (1,207th)	Close (30-Jun) $0.200 0 (0%)	Volume (30-Jun) 1,808,064	Shortsold (12-Jun) 8,499 (0.01%) (521st)
52w High $0.100	52w Low $0.059	P/E -	EPS 0

	Subject
	IXC IXC Ann: Half Yearly Report and Accounts
	1 (current) 2 3
	IXC IXC Ann: Upcoming Presentations at 48th Annual NANOS Meeting
	IXC IXC Ann: New Executive Director and Chairman Agreements
	IXC IXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IXC IXC Ann: Notice of Investor Call and Appendix 4C
	IXC IXC Ann: Change of Registry Address
	IXC IXC Ann: UK R&D Tax Rebate
	IXC IXC Ann: Appointment IIH EVOLVE Phase III Trial Steering Group Chair
	IXC IXC Ann: Results of Meeting
	IXC IXC Ann: Chairman's Address to Shareholders at AGM
	IXC IXC Ann: Withdrawal of AGM Resolutions
	IXC IXC Ann: Invex to Present at Bell Potter Healthcare Conference
	IXC IXC Ann: Notice of Webinar & Investor Presentation
	IXC IXC Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
	IXC IXC Ann: Notice of Annual General Meeting/Proxy Form
	IXC IXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IXC IXC Ann: Presentation at EANS 2021 Congress
	IXC IXC Ann: Date of AGM and Closing Date for Director Nominations
	IXC IXC Ann: Notice of Investor Call and Presentation
	IXC IXC Ann: Exclusive Collaboration and Manufacturing Agreement
	IXC IXC Ann: Trading Halt
	IXC IXC Ann: Corporate Governance Statement
	IXC IXC Ann: Appendix 4G
	IXC IXC Ann: Appendix 4E and Annual Report
	IXC IXC Ann: Invex Granted Key European Patent for Exenatide
	IXC IXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IXC IXC Ann: Appendix 2A
	IXC IXC Ann: Notice of Upcoming Release of Securities from Escrow
	IXC IXC Ann: Investor Presentation
	IXC IXC Ann: Invex Receives Written Response from FDA on Type C Meeting
	IXC IXC Ann: Formulation and Manufacturing Update
	IXC IXC Ann: Invex Granted Type C Meeting with FDA
	IXC IXC Ann: Appendix 4C - quarterly
	IXC IXC Ann: Appendix 3G
	IXC IXC Ann: Change of Director's Interest Notice
	IXC IXC Ann: Results of Meeting
	IXC IXC Ann: Chairman's Address to Shareholders
	IXC IXC Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
	IXC IXC Ann: Investor Presentation
	IXC IXC Ann: Invex to Present at Upcoming Small Caps Conference
	IXC IXC Ann: Postcard to Shareholders
	IXC IXC Ann: Notice of General Meeting/Proxy Form
	IXC IXC Ann: US Trademark Granted for Presendin
	IXC IXC Ann: Initial Director's Interest Notice
	IXC IXC Ann: Invex Appoints Dr Megan Baldwin as Non-Executive Director
	IXC IXC Ann: Half Yearly Report and Accounts
	IXC IXC Ann: Appendix 4C - quarterly
	IXC IXC Ann: Invex Successfully Concludes Protocol Assistance with EMA
	IXC IXC Ann: Ceasing to be a substantial holder
	IXC IXC Ann: Invex to Present at Bell Potter Healthcare Conference

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
30-Jun	$0.09	893	0.00 (0.00%)
27-Jun	$0.09	1,213	0.00 (0.00%)
26-Jun	$0.09	8,195	0.00 (2.20%)
24-Jun	$0.09	63,912	+0.00 (4.60%)
23-Jun	$0.09	0	0.00 (0.00%)
20-Jun	$0.09	3	+0.00 (2.35%)
19-Jun	$0.09	0	0.00 (0.00%)
18-Jun	$0.09	35,930	-0.01 (6.59%)
16-Jun	$0.09	0	0.00 (0.00%)
13-Jun	$0.09	8,499	+0.00 (2.25%)
12-Jun	$0.09	322,263	0.00 (4.30%)
06-Jun	$0.09	465	0.00 (0.00%)
05-Jun	$0.09	20,000	0.00 (0.00%)
04-Jun	$0.09	0	0.00 (0.00%)
03-Jun	$0.09	0	0.00 (0.00%)
3 up, 3 down, and 9 flat days

High $0.21	Low $0.19	Trades 113	Turnover $359,726	Volume 1,808,064
30 June 2023 at 4:10pm

High $0.21	Low $0.19	Trades 113	Turnover $359,726	Volume 1,808,064
30 June 2023 at 4:10pm

Invex Therapeutics Ltd Health Care

$0.200 0.005 (2.56%)

$0.200 0.005 (2.56%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices